These molecular subtypes and their pathways could serve as key molecular hallmarks of epilepsy, offering valuable insights for developing targeted therapies. Moreover, our findings introduce a novel framework for classifying epilepsy based on its molecular nature, potentially connecting the clinical symptoms with the underlying causes more effectively.
Weng et al. (2026) studied this question.